Richard Chinnock

Prof. Richard Chinnock

Loma Linda University School of Medicine
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2010 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
MCMaria Rosa Costanzo
Maria Rosa Costanzo
ADAnne Dipchand
Anne Dipchand
RSRandall Starling
Randall Starling
Allen S. AndersonAllen S. Anderson
Allen S. Anderson
MCMichael Chan
Michael Chan
JVJohan Vanhaecke
Johan Vanhaecke

17 May 2001 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
GSGirish S. Shirali
Girish S. Shirali
JNJiyuan Ni
Jiyuan Ni
RCRichard Chinnock
Richard Chinnock
JJJoyce K. Johnston
Joyce K. Johnston
GRGeoffrey L. Rosenthal
Geoffrey L. Rosenthal
Jeffrey A. TowbinJeffrey A. Towbin
Jeffrey A. Towbin
The survival of recipients of cardiac allografts is limited by rejection and coronary vasculopathy. The purpose of this study in children who had received heart transplants was to evaluate the cardiac allografts for myocardial viral infections and to determine whether the presence of viral genome in the myocardium correlates with rejection, coronary vasculopathy, or graft loss.

1 July 1996 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
ARAnees J. Razzouk
Anees J. Razzouk
RCRichard Chinnock
Richard Chinnock
SGSteven R. Gundry
Steven R. Gundry
JJJoyce K. Johnston
Joyce K. Johnston
RLRanae L. Larsen
Ranae L. Larsen
LBLeonard L. Bailey
Leonard L. Bailey

18 November 1997 in Circulation
Verified
Journal Article
Closed access
PDF file
KSKenneth O. Schowengerdt
Kenneth O. Schowengerdt
JNJiyuan Ni
Jiyuan Ni
SDSusan W. Denfield
Susan W. Denfield
RGRobert J. Gajarski
Robert J. Gajarski
NBNeil E. Bowles
Neil E. Bowles
JTJeffrey A. Towbin
Jeffrey A. Towbin
Background Inflammatory diseases of the heart, including myocarditis and cardiac transplant rejection, are important causes of morbidity and mortality in children. Although viral infection may be suspected in either of these clinical conditions, the definitive etiology is often difficult to ascertain. Furthermore, the histology is identical for both disorders. Coxsackievirus has long been considered the most common cause of viral myocarditis; however, we previously demonstrated by polymerase chain reaction (PCR) analysis that many different, and sometimes unexpected, viruses may be responsible for myocarditis and cardiac rejection. In this study, we describe the association of parvovirus genome identified through PCR analysis of cardiac tissue in the clinical setting of myocarditis and cardiac allograft rejection. Methods and Results Myocardial tissue from endomyocardial biopsy, explant, or autopsy was analyzed for parvovirus B19 using primers designed to amplify a 699–base pair PCR product from the VP1 gene region. Samples tested included those obtained from patients with suspected myocarditis (n=360) or transplant rejection (n=200) or control subjects (n=250). Parvoviral genome was identified through PCR in 9 patients (3 myocarditis; 6 transplant) and no control patients. Of the 3 patients with myocarditis, 1 presented with cardiac arrest leading to death, 1 developed dilated cardiomyopathy, and the other gradually improved. Four of the 6 transplant patients had evidence of significant rejection on the basis of endomyocardial biopsy histology. All transplant patients survived the infection. Conclusions Parvovirus is associated with myocarditis in a small percentage of children and may be a potential contributor to cardiac transplant rejection. PCR may provide a rapid and sensitive method of diagnosis.

1 November 2012 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
RCRichard Chinnock
Richard Chinnock
SWS. A. Webber
S. A. Webber
ADA. I. Dipchand
A. I. Dipchand
RBR N Brown
R N Brown
JGJ. F. George
J. F. George
RBR. N. Brown
R. N. Brown
The objective was to determine the incidence and hazard for posttransplant lymphoproliferative disease (PTLD) in a study of 3170 pediatric primary heart transplants between 1993 and 2009 at 35 institutions in the Pediatric Heart Transplant Study. 147 of 151 reported malignancy events were classified as PTLD. Overall freedom from PTLD was 98.5% at 1 year, 94% at 5 years and 90% at 10 years. Freedom from PTLD was lowest in children (ages 1 to < 10 years) versus infants (<1 year) and adolescents (10 to < 18 years) with children at highest risk for PTLD with a relative risk of 2.4 compared to infants and 1.7 compared to adolescents. Positive donor EBV status was a strong risk factor for PTLD in the seronegative recipient, but risk magnitude was dependent on recipient age at the time of transplantation. Nearly 25% of EBV seronegative recipients of EBV+ donors at ages 4-7 at transplantation developed some form of PTLD. The overall risk for PTLD declined in the most recent transplant era (2001-2009, p = 0.003). These findings indicate that EBV status and the age of the recipient at the time of transplantation are important variables in the development of PTLD in the pediatric heart transplant recipient.

1 May 2005 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
MCM.R.K. Chrisant
M.R.K. Chrisant
DND.C. Naftel
D.C. Naftel
JDJ. Drummond-Webb
J. Drummond-Webb
RCRichard Chinnock
Richard Chinnock
CCC.E. Canter
C.E. Canter
WMW.R. Morrow
W.R. Morrow